Product Information
CONJUGATED ESTROGENS 1.25 MG TB is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $5.6026 per EA under NDC 50742039101. Its NADAC has been published 31 times since Jan 21, 2026.
FDA first approved this application on Oct 15, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742039101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ESTROGENS, CONJUGATEDApproval Type
Generic (ANDA)
FDA Application
ANDA214023FDA Approved
10/15/2025
TE Code
AB
On Market Since
10/16/2025
Pharmacological Classes
Price Statistics
The NADAC for CONJUGATED ESTROGENS 1.25 MG TB has been published 31 times since Jan 21, 2026, and over the history we have for it it has declined 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6026 per EA |
|---|---|
| All-time high | $5.9144 (Feb 11, 2026) |
| All-time low | $5.6026 (Aug 19, 2026) |
| 52-week high | $5.9144 |
| 52-week low | $5.6026 |
| Median price | $5.7057 |
| Average price | $5.7321 |
| Largest weekly change | -3.9% (Feb 18, 2026) |
| Weeks tracked | 31 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CONJUGATED ESTROGENS 1.25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CONJUGATED ESTROGENS 1.25 MG TB, manufactured by Ingenus Pharmaceuticals LLC, is $5.6026 per EA (NDC 50742039101), effective Aug 19, 2026.
How has the price of CONJUGATED ESTROGENS 1.25 MG TB changed over time?
Over the history we have for it, the NADAC for CONJUGATED ESTROGENS 1.25 MG TB has declined 5.3%. It has been tracked across 31 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for CONJUGATED ESTROGENS 1.25 MG TB?
Since Jan 21, 2026, the NADAC for CONJUGATED ESTROGENS 1.25 MG TB has ranged from a low of $5.6026 (Aug 19, 2026) to a high of $5.9144 (Feb 11, 2026), with a median of $5.7057 per EA.
Are there cheaper alternatives to CONJUGATED ESTROGENS 1.25 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CONJUGATED ESTROGENS 1.25 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CONJUGATED ESTROGENS 1.25 MG TB?
CONJUGATED ESTROGENS 1.25 MG TB (NDC 50742039101) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.